What did the Multimodal Treatment of Attention Deficit Hyperactivity Disorder (ADD) study find? The Multimodal Treatment of Attention Deficit Hyperactivity Disorder (ADD) study was designed to analyze major ADHD treatments that included medication therapy, in-depth behavioral therapy, or a consolidation of the two. An initial study of 14 months and a follow-up of 6-8 years was carried out (Molina et al., 2011). The ages of the children studied initially ranged from 7 to approximately 10 years. One of the findings indicated by the initial 14-month study was that the type of treatment (medication, behavioral therapy, community care, or combinations of treatments) did not predict how children would behave 6 to 8 years later, but could be used as an assumption on the type of behavior that might be displayed during adolescence (Molina et al., 2011). The combination of medication and behavioral therapy, rather than behavioral therapy alone or community care alone, indicated the best type of progress for participants in the initial 14-month study (Molina et al., 2011). The study revealed 3 sets of findings; there were no marked distinctions between children in the random group aged 7 to 9 years; symptom trajectory as a child predicted outcome at 6- and 8-year follow-up; Even with medications and behavioral therapy, the MTA group had lower functioning ability than the non-MTA sample at 2 years. What the study showed was that the disparity in treatment effects at delivery decreased when treatment was relaxed (Molina et al., 2011). The initial clinical aspect of ADHD in childhood which included the worst symptoms of ADHD, any conduct problems, the child's intellect, any social... means of paper... has a longer period of study. The authors of the MTA study certainly would have liked to conduct a longer study. If you could do something different in this study, or a new study similar to it, to study the effectiveness of different ADHD treatments, what would you do? otherwise? (Hint: You may or may not want more subjects, different types of treatments, longer follow-up periods, different measurement tools, more “real-life settings,” better quality control of psychotherapists, etc. Reference Molina, BSG , Hinshaw, S.P., Swanson, J.M., Arnold, L.E., Vitiello, B., Jensen, P.S., Epstein, J.N., & Hoza, B. (n.d.). http://www.ncbi.nlm.nih.gov/pmc/articles/. Retrieved from http://archpsyc.jamanetwork.com/article.aspx? articleid=205525